Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carboxylic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Lewis acid catalyzed synthesis offers high yield and safety for pharmaceutical intermediate manufacturing supply chains.
Patent CN111269194B reveals a novel paraformaldehyde cyclization route for indoxacarb intermediates, eliminating ethanol byproducts and enhancing supply chain reliability for agrochemical manufacturers.
Patent CN111138392B reveals a mild 90-120°C route to 2,5-Furandicarboxylic Acid from furfural using O2 and CO2, offering significant cost reduction in polymer additive manufacturing.
Novel patent CN113683574B enables high-purity synthesis for HBV intermediates with optimized supply chain reliability and cost efficiency.
Patent CN105418561B reveals bifunctional catalyst for FDCA. Enhances supply chain reliability and cost reduction in polymer synthesis additives manufacturing.
Novel synthesis of triazine hydroxyethyl ethylenediamine polycarboxylic acid using cyanuric chloride. Cost-effective rust inhibitor for industrial applications with superior stability.
Patent CN116396950A reveals a novel carboxylesterase mutant for efficient (R)-3-cyclohexene-1-carboxylic acid production, offering superior stereoselectivity and scalable biocatalysis for API intermediates.
Novel EDCI-mediated method for liquid crystal intermediates. Reduces toxicity and simplifies purification for electronic chemical manufacturing supply chains and operational costs significantly.
Patent CN109182298A reveals high-efficiency CALB mutants for chiral intermediate synthesis, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN116622672A reveals high-efficiency carboxylesterase mutants for chiral acid production, offering cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN117535268A reveals high-purity esterase resolution. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN113481181B details a novel esterase mutant for resolving indoline derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN107840828B reveals a high-yield one-step fluorination route for 2-chloro-5-trifluoromethylpyrazine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis patent CN103864618A offers high yield and mild conditions for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Novel Pd-NHC catalyzed process offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability for global partners.
Patent CN1023117C details a novel oxidation route for 2,2'-biphenyldicarboxylic acid using ruthenium tetroxide and sodium hypochlorite, offering significant cost and purity advantages.
Patent CN102875455A reveals a scalable Hofmann degradation route for 3,6-dichloro-2-aminopyridine, eliminating cryogenic lithiation and reducing manufacturing costs significantly.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN1019300B reveals a direct acylation method for 7-amino-cephalosporins using acid salts, offering superior purity and cost efficiency for pharmaceutical manufacturers.